NYSE - Delayed Quote USD

Cardinal Health, Inc. (CAH)

103.21 -0.60 (-0.58%)
At close: April 26 at 4:00 PM EDT
103.28 +0.07 (+0.07%)
After hours: April 26 at 7:49 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jason M. Hollar CEO & Director 3.95M -- 1973
Mr. Aaron E. Alt Chief Financial Officer 2.19M -- 1973
Ms. Jessica L. Mayer Chief Legal & Compliance Officer 1.48M 13.04k 1970
Mr. Stephen M. Mason Chief Executive Officer of Medical Segment 1.23M 219.53k 1972
Ms. Deborah L. Weitzman Chief Executive Officer of Pharmaceutical Segment 1.4M -- 1965
Ms. Patricia M. English Senior Vice President 451.34k -- 1980
Ms. Mary C. Scherer Senior VP & Chief Accounting Officer -- -- --
Ms. Michelle D. Greene Executive VP, Chief Information Officer & Customer Support Services -- -- 1971
Matt Sims Vice President of Investor Relations -- -- --
Ms. Ola M. Snow Chief Human Resources Officer -- -- 1968

Cardinal Health, Inc.

7000 Cardinal Place
Dublin, OH 43017
United States
614 757 5000 https://www.cardinalhealth.com
Sector: 
Healthcare
Full Time Employees: 
47,040

Description

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Corporate Governance

Cardinal Health, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 1. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 23, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 22, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 15, 2024
    Dividend Date
  • Mar 28, 2024
    Ex-Dividend Date
  • Feb 28, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing

Upcoming Events

May 02, 2024
Cardinal Health, Inc. Earnings Call

Related Tickers